PV Reporter partners with PAN Foundation on MPN Patient Assistance Programs

Patient Assistance Programs, Medications for MPN Patients

by David Wallace

PV Reporter is very proud to announce a new partnership with the PAN Foundation.  Myeloproliferative Neoplasm (MPN) patients may be eligible for $8,500 per year (or more if a 2nd grant is needed/approved) in assistance assuming you meet the eligibility criteria which are very reasonable.

PAN Foundation PV Reporter



The status is presently open and you can apply online or call 1-866-316-7263.  Their coverage for MPN patients is very comprehensive.  A few of the drugs include:

  • Jakafi
  • Pegasys (peginterferon alfa-2a)
  • Hydrea
  • Intron A (interferon alfa-2b)
  • Anagrelide Hcl
  • Prednisone
  • Busulfun
  • Danazol

MPN patient assistance programs PAN FoundationPlease check out the PAN Foundation website for a complete list.

The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications.  Since its founding in 2004, PAN has provided nearly 1 million under insured patients with over $3 billion in financial assistance, through close to 70 disease-specific programs.


About David Wallace

Founder of PV Reporter, a resource for Myeloproliferative Neoplasm (MPN) patients and caregivers. After being diagnosed with Polycythemia Vera (PV) in 2009, I utilized social media to connect with "informed patients" and develop a better understanding of emerging treatment options. My philosophy on patient care is straight forward - "educating the patient is essential, so the patient can guide their physician to meet his or her needs." PV Reporter is a comprehensive resource hub giving visitors vital tools to become "empowered patients."

error: Content is protected !